Immunoblot analysis of the human antibody response to respiratory syncytial virus infection
- PMID: 3572364
- DOI: 10.1099/0022-1317-68-5-1267
Immunoblot analysis of the human antibody response to respiratory syncytial virus infection
Abstract
The protein specificities of the antibodies induced during natural respiratory syncytial (RS) virus infection in humans were investigated using immunoblotting of human sera against virus proteins resolved by gel electrophoresis. Sera from 33 patients, who had complement-fixing antibodies against RS virus, were analysed. All the patients showed a response against the virus nucleoprotein (VPN41) and glycoprotein (VGP48). Antibodies against the virus proteins GP90, VPP32, VPM27 and two proteins of molecular weights 24,800 and 23,700 were also demonstrated. The spectrum of protein specificities of the antibodies varied among patients. There was an increase in the level of antibody for these virus proteins between the acute and convalescent serum samples from five patients. The protein specificities of the IgG and IgM antibodies were determined for five patients; VPN41, VPP32 and VPM27 induced IgG and IgM in all of these sera. Two of the five patients had detectable IgG but not IgM antibodies against VGP48, whereas the remaining three sera had detectable VGP48-specific IgG and IgM antibodies.
Similar articles
-
Monoclonal antibody-based capture enzyme immunoassays for specific serum immunoglobulin G (IgG), IgA, and IgM antibodies to respiratory syncytial virus.J Clin Microbiol. 1990 Dec;28(12):2744-9. doi: 10.1128/jcm.28.12.2744-2749.1990. J Clin Microbiol. 1990. PMID: 2280004 Free PMC article.
-
Antibodies to respiratory syncytial virus polypeptides and their significance in human infection.J Gen Virol. 1983 Sep;64 (Pt 9):1867-76. doi: 10.1099/0022-1317-64-9-1867. J Gen Virol. 1983. PMID: 6886679
-
IgG and IgM antibodies to viral glycoproteins in respiratory syncytial virus infections of graded severity.Arch Dis Child. 1989 Dec;64(12):1661-5. doi: 10.1136/adc.64.12.1661. Arch Dis Child. 1989. PMID: 2624472 Free PMC article.
-
The production of monoclonal antibodies against respiratory syncytial virus and its clinical applications.Clin Lab Med. 1985 Sep;5(3):589-613. Clin Lab Med. 1985. PMID: 3899483 Review.
-
[The status of research to develop new vaccines against infection caused by the respiratory syncytial virus].Vopr Virusol. 1988 Sep-Oct;33(5):523-9. Vopr Virusol. 1988. PMID: 3064426 Review. Russian. No abstract available.
Cited by
-
Antibody-dependent enhancement of respiratory syncytial virus infection by sera from young infants.Clin Diagn Lab Immunol. 1994 Nov;1(6):670-7. doi: 10.1128/cdli.1.6.670-677.1994. Clin Diagn Lab Immunol. 1994. PMID: 8556519 Free PMC article.
-
Monoclonal antibody-based capture enzyme immunoassays for specific serum immunoglobulin G (IgG), IgA, and IgM antibodies to respiratory syncytial virus.J Clin Microbiol. 1990 Dec;28(12):2744-9. doi: 10.1128/jcm.28.12.2744-2749.1990. J Clin Microbiol. 1990. PMID: 2280004 Free PMC article.
-
Immunoglobulin A antibody response to respiratory syncytial virus structural proteins in colostrum and milk.J Clin Microbiol. 1989 Sep;27(9):1949-51. doi: 10.1128/jcm.27.9.1949-1951.1989. J Clin Microbiol. 1989. PMID: 2778061 Free PMC article.
-
Prevalence of antibodies against HEp-2 cell antigen in infants and children hospitalized with respiratory syncytial virus infection.Infection. 1996 Nov-Dec;24(6):407-11. doi: 10.1007/BF01713039. Infection. 1996. PMID: 9007586
-
A novel subnucleocapsid nanoplatform for mucosal vaccination against influenza virus that targets the ectodomain of matrix protein 2.J Virol. 2014 Jan;88(1):325-38. doi: 10.1128/JVI.01141-13. Epub 2013 Oct 23. J Virol. 2014. PMID: 24155388 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources